Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
146.14
-0.68 (-0.46%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
92
93
Next >
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer
Via
Benzinga
Elliott Wave Technical Analysis: Johnson & Johnson
December 06, 2023
Looking for longs into wave (v).
Via
Talk Markets
Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential
December 06, 2023
While it might be tempting to jump onboard the top winners in the S&P 500, these bargain stocks might offer superior upside.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy
December 06, 2023
Johnson & Johnson's (NYSE: JNJ) worldwide vice president for litigation, Erik Haas, disclosed recent settlements with several law firms regarding claims linking J&J talc
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3
December 05, 2023
Warren Buffett stocks are typically bought to be held for a long time but sometimes even he finds it necessary to sell.
Via
InvestorPlace
This Is What Whales Are Betting On Johnson & Johnson
November 27, 2023
Via
Benzinga
Is NYSE:JNJ suited for dividend investing?
November 27, 2023
Exploring JOHNSON & JOHNSON (NYSE:JNJ)'s dividend characteristics.
Via
Chartmill
Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24
December 05, 2023
Johnson & Johnson (NYSE: JNJ) expects operational sales growth in the
Via
Benzinga
Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits
December 05, 2023
Via
Benzinga
Nasdaq 100 Forecast: Stocks Slip For A Second Day With Jobs Data In Focus
December 05, 2023
Stocks are heading for a second day of losses as investors look ahead to data releases ahead of Friday's key non-farm payroll and next week's FOMC meeting.
Via
Talk Markets
The 7 Best Ways to Invest $1,000 in the Stock Market Now
December 04, 2023
Take a look at the seven best ways to invest $1,000 in the stock market and build a portfolio that generates passive income and gains.
Via
InvestorPlace
Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure
December 04, 2023
The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit, potentially...
Via
Benzinga
Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
December 03, 2023
The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in th
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Warren Buffett Just Closed His Position in This Dividend Giant. Should You?
December 03, 2023
J&J has a long track record of dividend growth -- something Buffett generally appreciates.
Via
The Motley Fool
Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
December 02, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections
December 01, 2023
UBS has upgraded Johnson & Johnson (NYSE: JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is...
Via
Benzinga
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
December 01, 2023
Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepresented the efficacy of its widely-
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Investors Should Not Pay More Than A 15 P/E Ratio When Buying A Stock
December 01, 2023
A look at how the P/E ratio can help determine if a stock is trading at a fair valuation or not, and whether it is a good investment.
Via
Talk Markets
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
December 01, 2023
Faced with a possible negative outcome in the market, these top healthcare stocks should offer the confidence you need.
Via
InvestorPlace
Warren Buffett Reduced This Long-Time Berkshire Hathaway Holding by 67%. Should Investors Follow His Lead?
December 01, 2023
Berkshire Hathaway trimmed several longtime holdings in the third quarter, including this stock it has held since 2001.
Via
The Motley Fool
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
November 30, 2023
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company's Covid-19
Via
Talk Markets
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
7 Blue-Chip Stocks to Buy for 2024, According to AI
November 30, 2023
Technical indicators can predict stock prices when paired with fundamental analysis. Here's MarketMasterAI's latest blue chip stock picks.
Via
InvestorPlace
Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns
November 30, 2023
Are you looking for income kings with reliable returns? Here are seven blue-chip dividend stocks for reliable returns.
Via
InvestorPlace
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
November 30, 2023
There have not been many successful IPOs in 2023, so finding stock picks from the Renaissance IPO ETF won’t be easy.
Via
InvestorPlace
Topics
ETFs
Initial Public Offering
Exposures
Securities Market
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tuesday, the FDA said it received reports of patients developing T-cell malig
Via
Benzinga
Exposures
Product Safety
The 7 Biggest Dividend Stocks in Warren Buffett’s Portfolio
November 29, 2023
Are you curious about those Warren Buffet dividend stocks he owns in his portfolio? This article has you covered on the most important names.
Via
InvestorPlace
2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now
November 28, 2023
With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors.
Via
The Motley Fool
Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering
November 28, 2023
Dutch biotech startup Cradle has raised $24 million in Series A funding as it looks to boost its protein design and engineering process.
Via
Benzinga
3 Robotics Stocks That Could Be Multibaggers in the Making
November 28, 2023
These robotics stocks all deserve a place in your portfolio. Each company has unique value catalysts which make them worthy of consideration.
Via
InvestorPlace
The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold)
November 27, 2023
The Oracle of Omaha buys a lot of different companies but the one stock that Warren Buffet just bought may surprise you.
Via
InvestorPlace
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
92
93
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.